Pastilles surge again as SAS-B data shows strong start to 2026 by Steve Jones February 2, 2026February 3, 2026 Pastilles accounted for almost three out of 10 approved prescriptions through the Special Access Scheme in […]
Pastilles climb past oil to become second largest SAS-B dosage form by Steve Jones December 2, 2025December 4, 2025
October SAS-B approvals hit second highest number on record by Steve Jones November 3, 2025November 4, 2025
Pastilles overtake oil among 18-44 age group as SAS-B approvals near 2024 total by Steve Jones October 1, 2025October 1, 2025
July SAS-B approvals edge higher as pastilles share rises beyond 20% by Adam Sheldon August 5, 2025August 6, 2025
Two-month total of SAS-B approvals up 47% on 2024, TGA data shows by Steve Jones March 4, 2025April 1, 2025
Growth of pastilles accelerates as SAS approvals get off to strong start in 2025 by Steve Jones February 17, 2025February 17, 2025
May SAS-B approvals hold steady as THC-only product remains dominant by Steve Jones June 3, 2024June 3, 2024
Pastilles gaining in popularity as SAS-B approvals maintain strong start to 2024 by Steve Jones May 6, 2024July 16, 2024
SAS-B deep dive: more women turn to flower and anxiety on the rise as cannabis sands continue to shift by Steve Jones January 17, 2024July 11, 2024
